Magnitude of Drug–Drug Interactions in Special Populations
Drug–drug interactions (DDIs) are one of the most frequent causes of adverse drug reactions or loss of treatment efficacy. The risk of DDIs increases with polypharmacy and is therefore of particular concern in individuals likely to present comorbidities (i.e., elderly or obese individuals). These sp...
Main Authors: | Sara Bettonte, Mattia Berton, Catia Marzolini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/4/789 |
Similar Items
-
MAIN APPROACHES TO EFFICACY EVALUATION OF SPECIALIZED PRODUCTS FOR PREGNANT WOMEN
by: I.Ya. Kon', et al.
Published: (2011-01-01) -
Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life
by: Nicola Pugliese, et al.
Published: (2023-11-01) -
Risk of Polypharmacy and Its Outcome in Terms of Drug Interaction in an Elderly Population: A Retrospective Cross-Sectional Study
by: Reham M. Alhumaidi, et al.
Published: (2023-06-01) -
Potential Drug–Drug Interactions and Related Factors among Geriatric Outpatients of a Tertiary Care Hospital
by: Tippayavadee Wannawichate, et al.
Published: (2023-11-01) -
Drug therapy, potential interactions and iatrogenesis as factors related to frailty in the elderly
by: Andressa Rodrigues Pagno, et al.
Published: (2018-10-01)